Inventor · disambiguated record
Ivan Gout
Also filed as: GOUT IVAN · GOUT IVAN TARASOVICH
13 granted patents·4 pending applications·262 citations·filing 1993–2017
92Inventor score
Files withLUDWIG INST CANCER RES8LUDWIG INST FOR CANCER RES LTD2RITTER GERD2UCL BUSINESS PLC2GOUT IVAN1
Top patents by PatentIndex Score
17 records- 0195US5824492APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1993·Granted Oct 20, 1998·127 cites·7 claims
- 0292US8603474B2Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapyRITTER GERD·Filed 2009·Granted Dec 10, 2013·27 cites·11 claims
- 0385US6274327B1Polypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1998·Granted Aug 14, 2001·40 cites·10 claims
- 0478US9045533B2Membrane transporter NaPi2b (SCL34A2) epitope antibodiesRITTER GERD·Filed 2013·Granted Jun 2, 2015·3 cites·8 claims
- 0573US5846824APolypeptides having kinase activity, their preparation and useLUDWIG INST CANCER RES·Filed 1997·Granted Dec 8, 1998·43 cites·8 claims
- 0664US7335467B2Breast cancer antigensLUDWIG INST CANCER RES·Filed 2002·Granted Feb 26, 2008·4 cites·28 claims
- 0758US7998718B2Identification and functional characterization of a novel ribosomal S6 protein kinaseLUDWIG INST FOR CANCER RES LTD·Filed 2004·Granted Aug 16, 2011·0 cites·11 claims
- 0853US10385138B2Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapyINSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NAT ACADEMY OF SCIENCE OF UKRANE·Filed 2017·Granted Aug 20, 2019·0 cites·9 claims
- 0953US9701755B2Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapyLUDWIG INST FOR CANCER RES LTD·Filed 2015·Granted Jul 11, 2017·0 cites·13 claims
- 1049US7422849B1Method for determining expression of a PI3 kinase geneLUDWIG INST CANCER RES·Filed 1999·Granted Sep 9, 2008·5 cites·10 claims
- 1148US8669347B2Truncated variant of the mammalian target for rapamycin (MTOR) proteinNEMAZANYY IVAN·Filed 2008·Granted Mar 11, 2014·0 cites·1 claims
- 1247US5741689AMethods to inhibit serine kinase activity and to alter intersubunit binding activity of phosphatidylinositol 3-kinase, and serine kinase active sequence of the sameLUDWIG INST CANCER RES·Filed 1994·Granted Apr 21, 1998·10 cites·28 claims
- 1346US2014120099A1TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINUCL BUSINESS PLC·Filed 2013·Application pending·0 cites
- 1442US2017145391A1TRUNCATED VARIANT OF THE MAMMALIAN TARGET FOR RAPAMYCIN (mTOR) PROTEINLUDWIG INST CANCER RES·Filed 2017·Application pending·0 cites
- 1536US2016257927A1Three-dimensional cell culture using nanofiber slurries and nano-structured substratesUCL BUSINESS PLC·Filed 2015·Application pending·0 cites
- 1636US2009181003A1Regulation of S6 Kinsase Protein Activity and Related MethodsGOUT IVAN·Filed 2006·Application pending·0 cites
- 1732US6830909B1Identification and functional characterization of a novel ribosomal S6 protein kinaseLUDWIG INST CANCER RES·Filed 1999·Granted Dec 14, 2004·3 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Ivan Gout files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →